Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
33.36
-0.65 (-1.91%)
Nov 20, 2026, 12:43 PM EST - Market open
Xencor Employees
Xencor had 260 employees as of December 31, 2025. The number of employees increased by 10 or 4.00% compared to the previous year. That makes Xencor the 24,979th largest employer in the world and 3,184th in the United States.
Employees
260
Change (1Y)
10
Growth (1Y)
4.00%
Revenue / Employee
$771,131
Profits / Employee
-$453,315
Market Cap
2.50B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 260 | 10 | 4.00% | 260 | 0 |
| Dec 31, 2024 | 250 | -30 | -10.71% | 250 | 0 |
| Dec 31, 2023 | 280 | -1 | -0.36% | 280 | 0 |
| Dec 31, 2022 | 281 | 27 | 10.63% | 281 | 0 |
| Dec 31, 2021 | 254 | 52 | 25.74% | 254 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Telix Pharmaceuticals | 1,184 |
| ADMA Biologics | 647 |
| Arcus Biosciences | 601 |
| Denali Therapeutics | 507 |
| Celldex Therapeutics | 198 |
| Pharvaris | 168 |
| Celcuity | 155 |
XNCR News
- 1 day ago - Xencor price target raised to $37 from $21 at JPMorgan - TheFly
- 11 days ago - Xencor announces initial dose-escalation data from Phase 1b study of plamotamab - TheFly
- 11 days ago - Xencor Presents Initial Plamotamab Data in Rheumatoid Arthritis at ACR Convergence 2026 and Updates Progress in First-in-Human Study of XmAb657 - Business Wire
- 15 days ago - Xencor price target raised to $40 from $39 at Canaccord - TheFly
- 15 days ago - Xencor reports Q3 EPS 50c, consensus (34c) - TheFly
- 15 days ago - Xencor Reports Third Quarter 2026 Financial Results - Business Wire
- 16 days ago - Xencor Quarterly report: Q3 2026 - Filings
- 16 days ago - Xencor Earnings release: Q3 2026 - Filings